Referral Process: CAR T-Cell Therapy

EP: 1.Importance of Collaboration between Academic and Community Centers

EP: 2.Referral Process: Streamlining and Challenges Seen

EP: 3.Referral Process: Bispecifics

EP: 4.Similarities and Differences among Bispecifics: BCMA vs non-BCMA

EP: 5.Types of Referrals and Impact of Social Factors on the Referral Process

EP: 6.Managing AEs Seen with Bispecifics

Now Viewing

EP: 7.Referral Process: CAR T-Cell Therapy

EP: 8.CAR T: Impact of Recent Approvals on the Referral Process

EP: 9.Long-Term Monitoring of AEs and Reintegrating Patients back into Community Care

EP: 10.Clinical Pearls about the Referral Process of Bispecifics and CAR-T in RRMM

Video content above is prompted by the following:

• Please talk about the referral process at your institution for patients with CAR T-cell therapy between community and academic centers.
• How can academic centers better support community oncologists in identifying eligible patients?
• How do you determine which patients are most suitable for referral to academic centers for these therapies?

What types of referrals do you usually do?

How do you manage patient expectations throughout the referral process?